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Lung tumor motion due to respiration poses a challenge in the application of 10 
modern three-dimensional conformal radiotherapy. Direct tracking of the lung 
tumor during radiation therapy is very difficult without implanted fiducial 
markers. Indirect tracking relies on the correlation of the tumor’s motion and the 
surrogate’s motion. The present paper presents an analysis of the correlation 
between the tumor motion and the diaphragm motion in order to evaluate the 15 
potential use of diaphragm as a surrogate for tumor motion. We have analyzed 
the correlation between diaphragm motion and superior-inferior lung tumor 
motion in 32 fluoroscopic image sequences from 10 lung cancer patients. A 
simple linear model and a more complex linear model that accounts for phase 
delays between the two motions have been used. Results show that the 20 
diaphragm is a good surrogate for tumor motion prediction for most patients, 
resulting in an average correlation factor of 0.94 and 0.98 with each model 
respectively. The model that accounts for delays leads to an average localization 
prediction error of 0.8mm and an error at the 95% confidence level of 2.1mm. 
However, for one patient studied, the correlation is much weaker compared to 25 
other patients. This indicates that, before using diaphragm for lung tumor 
prediction, the correlation should be examined on a patient-by-patient basis.  
 
1. Introduction 
 30 
It has been shown that modern three-dimensional radiation therapy is more successful at 
treating early stage lung cancer than older two-dimensional radiation therapy (Fang et al., 
2006). There is, however, a concern related to respiratory tumor motion. It has been 
shown that the motion amplitude can be clinically significant (~2-3 cm) (Keall et al., 
2006), depending on tumor location and individual patients. Tumor motion may greatly 35 
degrade the effectiveness of conformal radiotherapy for the management of lung cancer, 
especially when the treatment is done in a hypofractionated or single-fraction manner.  
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Various tumor motion compensation strategies have been investigated (Keall et al., 
2006; Jiang, 2006a). Advanced motion compensation techniques, such as beam gating 
(Jiang, 2006b) or beam tracking (Keall et al., 2001), rely on the precise knowledge of 
tumor position. There are mainly four different methods to determine tumor location 
during the treatment: 1) direct fluoroscopic tumor tracking (Cui et al., 2007; Xu et al., 5 
2007; Xu et al., 2008); 2) fluoroscopic tracking of the implanted fiducial markers (Sharp 
et al., 2004; Tang et al., 2007); 3) inference of the tumor position from anatomic 
surrogates such as abdomen surface (Berbeco et al., 2005b; Berbeco et al., 2006; Wu et 
al., 2008); and 4) non-radiographical tumor tracking through implanted transponders 
(Seiler et al., 2000; Balter et al., 2005). 10 
Tumor tracking techniques based on implanted fiducial markers or wireless 
transponders, when applied to lung cancer, suffer from various clinical problems, such as 
the risks of pneumothorax (Geraghty et al., 2003; Arslan et al., 2002) and marker 
migration (Nelson et al., 2007). Therefore, these techniques are not suitable for lung 
tumor tracking. Techniques for direct fluoroscopic lung tumor tracking are still under 15 
development and there is a long way to go before its clinical use (Cui et al., 2007; Xu et 
al., 2007; Xu et al., 2008; Lin et al., 2009). Tumor localization based on anatomic 
surrogates has been implemented clinically for gated lung cancer radiotherapy, using 
commercial products such as the Real-Time Position Management (RPM) system (Varian 
Medical Systems, Inc, Pala Alto, CA, USA) (Jiang, 2006b). This kind of techniques is 20 
accurate only when there is a good correlation between lung tumor motion and the 
motion of the anatomic surrogate. Therefore, it is crucial to have a clear understanding on 
the correlation between tumor and a particular surrogate before this surrogate is used to 
derive the tumor location.    
The most commonly used anatomic surrogate is the antero-posterior (AP) motion of  25 
the abdominal surface (Jiang, 2006b; Kanoulas et al., 2007; Wu et al., 2008; Ruan et al., 
2008). Vedam et al have shown that the abdominal surface motion correlates strongly 
with diaphragm motion (Vedam et al., 2003). However, some other studies show that the 
correlation between tumor motion and abdominal surface motion or between abdominal 
surface motion and diaphragm motion depends on individual patients and treatment 30 
fractions and cannot be generalized (Bruce, 1996; Hoisak et al., 2004, 2006; Tsunashima 
et al., 2004). When abdominal surface motion is used to generate gating signal, the tumor 
residual motion can be large (Berbeco et al., 2005b; Berbeco et al., 2006) and about 30% 
of the time the radiation beam will miss the target (Wu et al., 2008). Patient breath 
coaching or updating the internal/external correlation using low frequency x-ray imaging 35 
can improve the accuracy gated radiotherapy based on abdominal surface motion (Jiang, 
2006b; Kanoulas et al., 2007; Wu et al., 2008).  
Intuitively, anatomic surrogates inside the thorax, such as carina or diaphragm, 
should correlate better with lung tumor motion compared to abdominal surface. Van der 
Weide et al. found that there is a good correlation between carina and lung tumor motion 40 
and concluded that carina is a better internal surrogate than diaphragm (van der Weide et 
al., 2008). However, when estimating the correlation between diaphragm and lung tumor 
motion, they did not take in account the phase shift between two motions, which 
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underestimates the correlation. Zhang et al. evaluated tumor position prediction from 
diaphragm with a linear model that compensated for phase shift between tumor and 
diaphragm motions (Zhang et al., 2007). They performed the study only for 4 patients. 
Both studies are based on 4D-CT data, which consists on only one fictitious breathing 
cycle. We believe that the diaphragm is more suitable than carina for clinical application 5 
due to its high visibility in fluoroscopic images, if there is a good correlation between 
diaphragm and lung tumor motion. Therefore, we feel there is a need to carefully and 
comprehensively examine the correlation of lung tumor position with diaphragm position 
using image sequences consisting on many breathing cycles.  
The goal of this project is to analyze the correlation between the motions of the 10 
diaphragm and the lung tumor in order to evaluate whether diaphragm can be used as an 
internal anatomic surrogate for predicting lung tumor position. Diaphragm, as opposed to 
tumor, can be easily detected in fluoroscopic images (Chen et al., 2001; Berbeco et al., 
2005a; Vedam et al., 2003). 
 15 
2. Methods and Materials 
 
2.1 Patient image data 
 
A retrospective analysis was performed based on 32 AP fluoroscopic sequences from 10 20 
different lung cancer patients who underwent hypofractionated radiotherapy at the 
Moores Cancer Center, University of California San Diego (UCSD). The fluoroscopic 
images were acquired before or after treatment, at different treatment fractions, using an 
on-board x-ray imaging (OBI) system (Varian Medical Systems, Inc., Palo Alto, CA, 
USA). Each fluoroscopic sequence consists of an average of 513 images (320 to 701) that 25 
were acquired at a rate of 15 frames per second. Each image has 1024x768 pixels, with 
pixel size of either 0.243mm or 0.259mm, depending on the sequence. Tumor position 
was manually marked in each frame by an expert observer, and was considered as the 
ground truth. When tumor was not easily identified in the fluoroscopic sequence, an 
anatomical feature close to the tumor and easy to detect was marked instead.  The 30 
position of diaphragm was automatically detected by thresholding the image and 
applying a maximum gradient algorithm. The position of the apex of the diaphragm was 
recorded for all the sequences and frames. 
 
2.2 Overview of the model construction 35 
 
In order to observe the correlation between diaphragm and tumor motions, two different 
models for tumor motion prediction based on diaphragm motion were developed. First 
we used a linear model where tumor position was derived from the concurrent diaphragm 
position (Model 1). Then, to take into account the possible phase shift between tumor 40 
motion and diaphragm motion, we developed a more complex linear model where the 
concurrent diaphragm position and an optimal set of past positions of the diaphragm were 
considered as surrogates (Model 2). Two different analyses were performed on both 
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models: 1) a goodness of fit study, where the models were built based on all the images 
of the sequence, i.e., training set consisted on all the images in the sequence; and 2) a 
prediction power study, where the models were built based on the first 200 images 
(training set), corresponding to 13.3 seconds, and prediction errors were computed during 
the rest of the sequence (testing set). In order to eliminate the noise inherent to the 5 
manual identification of the tumor position, tumor trajectories were filtered (in time) 
using a 5-point median filter. All our algorithms have been implemented on Matlab 7.4 
platform.  
 
2.3 Model construction 10 
 
Two different sets of surrogates have been considered for each patient, resulting in two 
different models (Model 1 and Model 2). Both models follow a procedure similar to that 
described by Zhang et al (2007). The objective of these models is to establish the linear 
relationship between tumor displacement ˜ y(t) and surrogate displacement ˜ s(t) : 15 
˜ y(t)  B˜ s(t) ,        (1) 
where ˜ s(t)  [ ˜ s1(t), ˜ s2(t),..., ˜ sN (t)]T is the vector with the surrogate displacements (in this 
section of the paper vectors and matrices are indicated in bolded font), t denotes time, and 
N is the number of surrogates used in the model. ˜ y(t)  and ˜ s(t)  are displacements of the 
tumor position y(t) and surrogates position s(t)  with respect to their mean position y  and 20 
s  (that is, ˜ s(t)  s(t) - s and ˜ y(t)  y(t)  y ). Note that, while Zhang et al (2007) perform 
a non-rigid registration of the entire images in order to find the deformation field for all 
the pixels in the image, we have only considered the motions of tumor centroid and 
surrogates. Still the same method has been used here because of its generalizability to 
more complex structures, such tracking different tumors or different points within the 25 
image at the same time. Constructing a vector p that contains the tumor superior-inferior 
(SI) position y and the surrogates p(t)=[y(t), s1(t), s2(t), … , sN(t)]T, and performing a 
Principal Component Analysis (PCA) on p(t) (notice that there are only as many as N 
principal components), we can express any p(t) as a linear combination of the 
eigenvectors obtained from the PCA: 30 
p(t)  p  wk (t)ek
k1
N ,       (2) 
where ek are the eigenvectors of the analysis (components), wk are the corresponding 
coefficients in the linear combination, and p  [y ,s 1,...,s N ] is the mean value of p(t). Eq. 
(2) can be written in matrix form as: 
˜ p  p(t)  p  EW        (3) 35 
where   E  [e1,K,eN ]  and   W  [w1,K,wN ] . Noting that ˜ p  [ ˜ y, ˜ s1,..., ˜ sN ]T  , we can split 
Eq. (3) into two different equations: 
5 L I Cerviño et al. 
5 
˜ y  EyW
˜ s  EsW
          (4) 
where Ey  and Es are the upper row and the N lower rows of E respectively. Eliminating 
W in Eq. 4 and assuming that Es is invertible, we obtain: 
˜ y  EyEs1˜ s(t)  B˜ s(t)  ,      (5) 
which is the relationship we were looking for in Eq. (1). 5 
 
Model 1 (one surrogate): for the construction of the first model the position of the tumor 
y0 at time t0 is derived from only one surrogate, i.e., the position of the diaphragm s0 at 
the same time instant (see Figure 1). The equation of the model is: 
y0  a  bs0 ,           (5) 10 
where the coefficients a and b are considered constant, and are obtained from the 
procedure indicated previously (note that a  y  and b  B). a and b are considered as 
constants in the model.  
 
Figure 1: Representation of tumor and diaphragm motion variables used in the construction 15 
of models 1 and 2. 
 
 
Model 2 (optimal set of surrogates): for the construction of the second model, the 
position of the tumor at time t0 is expressed as a linear function of an optimal set of 20 
surrogates that includes the current position of the diaphragm s0 and an optimal 
combination of past diaphragm positions (Figure 1). The relationship between tumor 
position and diaphragm are expressed by: 
0s
1s
2sis
Diaphragm motion 
y
Tumor motion 
0
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y0  a  bisi
i
N ,          (6) 
where the summation includes only the optimal set plus the current position. Again, 
coefficients a and bi are considered constant during the whole sequence ( a  y  and 
[b1,...,bN ]  B ). Adding the diaphragm position at past times to the model we account for 
possible phase shifts and shape differences between diaphragm and tumor motions.  5 
We have selected a maximum N of 20, which allows for more than 1 second delay 
between motions. An exhaustive search among all the possible subsets of these surrogates 
to find the optimal subset would lead to about 0.5 million searches. Instead, a subset of 
surrogates close to optimal was obtained by the Sequential Forward Floating Search 
(SFFS) (Pudil et al., 1994). Sequential feature selection algorithms search for features in 10 
a sequential deterministic manner to find a suboptimal subset of features with respect to 
an evaluation criterion J. Forward methods start with an empty subset and sequentially 
add new features to achieve optimality. SFFS is a feature selection technique that 
provides close to optimal solution at an affordable computational cost (Jain et al., 2000). 
The SFFS method comprises the following steps: 15 
 
Step 1: Inclusion (Sequential Forward Search, SFS) 
Step 2: Conditional exclusion 
Step 3: Continuation of conditional exclusion 
 20 
At Step 1 one feature among the available features is added to the surrogate subset, so 
that the new subset maximizes the evaluation criterion J. At Step 2 a conditional 
exclusion is performed, that is, the worst feature in the updated subset is excluded from 
the set if by doing so a best evaluation criterion J is achieved. At Step 3 conditional 
exclusion steps continue until no further improvement in J is achieved. These 3 steps are 25 
iteratively repeated until no further improvement in J is found. 
In this study, the selection criterion J used for the feature selection in the SFFS 
method is the correlation coefficient obtained between the tumor position trajectory and 
the predicted position given by the selected surrogates during the training set. 
 30 
2.4 Goodness of fit 
 
In order to evaluate correlation, a Pearson’s correlation test was performed. Models 1 and 
2 were built based on the diaphragm position and the tumor position in the whole 
fluoroscopic sequence, for each sequence individually. The correlation between the real 35 
tumor position and the predicted tumor position given by each models was calculated, as 
well as the mean error ē and the maximum error at the 95% confidence interval e95 of the 
prediction.  
 
In addition, Model 1 has been used for comparison of model parameters between 40 
different sequences of the same patient.  We focus on variability of the slope b in Eq. (5) 
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of these models and the correlation coefficient of tumor and diaphragm motions for each 
patient. Variability has been computed as a percentage by calculating the standard 
deviation of the parameters divided by the average, and multiplying by 100.  
 
 5 
2.5 Prediction power 
 
In addition to calculating the correlation coefficient, an evaluation of the predictability of 
the models was performed. In this case, the first 200 frames of each sequence were used 
as the training set to build Models 1 and 2, and the remaining frames in the same session 10 
were used as testing data. For every sequence, models built with the training set were 
applied to predict tumor position in the testing set. Mean prediction error ē and 95-
percentile prediction error e95 are computed in the testing set in each sequence. 
 
3. Results 15 
 
3.1 Data analysis 
 
Table 1 shows, for each patient, the number of sequences analyzed, the average tumor 
motion range, the average delay between diaphragm and tumor motion, and the average 20 
distance between tumor and diaphragm. It can be observed that the average tumor motion 
ranged from 12 to 24mm, although individual sequence values ranged from 9mm to 
35mm. The average motion range among all the patients and sequences was found to be 
17mm. Delay between diaphragm and tumor motions was calculated with cross 
correlation of both signals (tumor and diaphragm trajectories). Mean delay and standard 25 
deviation are given for patients with more than one fluoroscopic sequence. Patients with 
several fluoroscopic sequences show a constant delay throughout all the series. Patient 2 
shows a standard deviation of 0.15 sec, mainly due to the fact that in some sessions the 
patient remains without breathing for prolonged periods of time, which affects the 
calculation of the delay.  30 
 
Table 1: Summary of patient data with number of sequences acquired for each patient, 
average tumor motion, and delay between diaphragm and tumor motion. 
Patient 
No. of 
sequences 
Average tumor 
motion (mm) 
Delay 
(sec) 
Average distance tumor-
diaphragm (mm) 
1 5 12 0.17±0.04 46 
2 6 13 0.34±0.15 41 
3 3 23 0.40±0.0 20 
4 2 17 0.00±0.0 81 
5 1 24 0.27 3 
6 3 16 0.00±0.0 2 
7 9 20 0.00±0.0 48 
8 1 13 0.00 14 
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9 1 18 0.13 9 
10 1 12 0.07 3 
 
 
3.2 Correlation between diaphragm and tumor motions 
 
Figure 2 shows the general trend of model performance for most patients: Model 1 (red 5 
hollow circles) proves a good correlation between diaphragm and tumor motion, which 
can be further improved by adding surrogates from the diaphragm history in Model 2 
(blue solid circles). A detail of the true target position and modeled position is shown. It 
can be seen that Model 2 corrects for a slight phase delay between diaphragm and target 
motions. The usual number of surrogates in the optimal subset ranges from 2 to 4 10 
surrogates. Although different sequences of the same patient may use a different subset of 
surrogates, they are similar. 
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Figure 2: Real tumor position (solid line) and tumor position predicted by Model 1 (red 
hollow circles) and Model 2 (blue solid circles) for Patient 1. Left: entire fluoroscopic 15 
sequence. Right: detail of a subinterval of the sequence to observe the difference between the 
two models. Patient shows a good correlation between diaphragm and tumor motion. Model 2 
corrects for a slight phase delay between tumor and diaphragm motions. 
 
Table 2 shows the results of the study of the correlation between diaphragm position 20 
and tumor position given by each model (Model 1 and Model 2). The training set in this 
study is the whole sequence. Correlation coefficient obtained with each model, average 
error ē, and localization error at 95% confidence level e95 are shown for each patient, as 
well as the average of all the sequences and patients. The average correlation coefficient 
between the tumor position and the estimated position given by Model 1 is 0.94, although 25 
it is always larger than 0.94 except for Patient3, who presents a correlation coefficient of 
0.76. It can be observed that Model 2 gives an average correlation value of 0.98 (range 
0.95-1.00). Model 2 gives smaller mean error (p<0.01) and 95-percentile error (p<0.01) 
and higher correlation coefficients (p<0.03) compared to Model 1. Model 2 gives an e95 
of less than 2.3mm except for Patient3.  30 
 
Table 2: Correlation results for Model 1 and Model 2: average correlation factor , 
average mean error ē, and average 95-percentile error e95 are shown. 
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Model 1 Model 2 Patient  ē (mm) e95 (mm)  ē (mm) e95 (mm) 
1 0.95 0.9 1.9 0.99 0.4 1.0 
2 0.97 0.7 1.8 0.98 0.6 1.4 
3 0.76 3.6 8.0 0.95 1.4 3.3 
4 0.96 0.8 2.0 0.97 0.7 1.6 
5 0.95 1.7 4.1 0.98 1.0 2.3 
6 0.99 0.6 1.3 1.00 0.3 0.8 
7 0.98 0.7 1.7 0.99 0.6 1.5 
8 0.94 0.7 1.8 0.95 0.7 1.7 
9 0.98 1.0 2.1 0.99 0.7 1.8 
10 0.95 0.9 2.2 0.97 0.8 1.7 
Average 0.94 1.1 2.7 0.98 0.7 1.7 
 
In patients with several series, it has been observed that parameters in Model 1 do not 
change greatly among fractions. The variability of the linear slope for Patients 1, 2, 4, 6 
and 7 is 9.0%, 4.4%, 8.3%, 3.5% and 18% respectively. Variability in Patient 7 is higher 
because of one series where patient showed much deeper inspirations and much more 5 
irregular breathing than in all the other series. The average variability is 8.6%. Variability 
of the correlation coefficient is 1.1%, 1.8%, 3.0%, 2.9% and 2.6% respectively 
 
3.3 Prediction  power 
 10 
To examine the prediction power of models for tumor locations based on diaphragm 
positions as surrogates, the first 200 frames of each sequence were used to build both 
models (training set) in each sequence independently. These models were used to predict 
tumor position in the remaining frames of the same sequence (testing set). The average 
correlation between real and predicted tumor position, and the average prediction errors ē 15 
and e95 of all sequences in each patient and the total average for all patients are shown in 
Table 3. It can be observed that correlation coefficients of the prediction are very similar 
to the ones previously obtained. On average, Model 2 improves tumor motion prediction 
e95 over Model 1 by almost 1mm. The average prediction e95 for all the sequences and all 
the patients is 2.1mm. The patient e95 averages range form 1.1mm to 4.6mm, this last 20 
value corresponding to Patient3. If Patient3 were excluded from the study, the e95 range 
would be 1.1-2.9mm. 
 
Table 3: Average prediction error for each patient given by the each model. 
Model 1 Model 2 
Patient  ē (mm) e95 (mm)  ē (mm) e95 (mm) 
1 0.94 1.0 2.1 0.98 0.6 1.3 
2 0.98 0.9 2.4 0.99 0.7 1.9 
3 0.77 3.7 8.1 0.96 1.5 4.6 
4 0.97 1.2 2.6 0.96 0.8 2.0 
5 0.94 1.8 4.2 0.98 1.1 2.9 
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6 0.99 0.6 1.3 0.99 0.5 1.1 
7 0.98 0.8 1.9 0.98 0.7 1.8 
8 0.92 0.7 1.6 0.92 0.7 1.6 
9 0.98 1.0 2.1 0.98 0.8 1.8 
10 0.96 1.0 2.1 0.97 0.8 1.7 
Total Average 0.94 1.3 2.8 0.97 0.8 2.1 
 
 
Figure 3 shows the prediction error for models 1 and 2 for all the patients and all the 
sequences. Model 2 gives smaller errors than Model 1 in all the studied cases. 
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Figure 3: Prediction error for Model 1 (left) and Model 2 (right) in all the sequences 
 
We have studied whether there is any correlation between motion range or tumor-
diaphragm distance and prediction error. Figure 4 shows the 95-percentile error e95 versus 
the motion range for all the fluoroscopic sequences, as well as a linear fit to this data. An 10 
increase of error with motion range is observed, although the R-square value of this fit is 
small. Figure 5 shows e95 versus the distance between diaphragm and tumor mean 
positions for each sequence, and the linear fit to this data. The small R-square value of 
this fit indicates that there is no correlation between both magnitudes. 
 15 
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Figure 4: 95-percentile prediction error versus motion range for all the fluoroscopic 
sequences of all the patients using Model 2. 
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Figure 5: 95-percentile prediction error versus tumor-diaphragm distance for all the 
fluoroscopic sequences of all the patients using Model 2. 
 
3.4 Outlier Patient 5 
 
During the model evaluation and correlation study we observed that all the patients 
showed good correlation factors and good model predictions, except for Patient 3. After 
analyzing one of Patient3’s sequences visually, we observed that the motion inside this 
patient’s lung seems at times inconsistent. For example, at times some structures inside 10 
the lung move while the diaphragm remains static (two different snapshots of one of the 
sequences of Patient3 are shown in Figure 6). These two temporary uncorrelated motions, 
possibly due to coughing, led to low overall correlation factors and poor model 
predictions. Analysis of the two other sequences of the same patient did not lead to any 
observation of such inconsistency in motion. Results, however, although better than in 15 
the sequence previously mentioned, were still worse than for other patients (prediction e95 
with Model 2 was 5.3mm and 3.6mm). Figure 7 shows the motion signal of the tumor 
and the diaphragm in a sequence of Patient3. It can be observed that not only the 
amplitude and phase are different, but also the shape of both motions is different, with the 
tumor showing more pronounced peaks. Tumor trajectory cannot be represented with a 20 
simple linear model such as Model 1. Model 2 corrects for phase delay and shape, 
although still regions in the breathing cycle are not well represented. A non-linear model 
should be explored for this patient.  
 
 25 
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Figure 6: Two snapshots of a fluoroscopic sequence of Patient3 highlighting the change of 
some of the underlying structures while the diaphragm does not move.  
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Figure 7: Diaphragm and real and estimated tumor positions for a sequence of Patient3.  
 
4. Discussion and conclusions 
 
This paper presents a study of the correlation between diaphragm motion and tumor 10 
craniocaudal motion based on 32 fluoroscopic sequences of 10 different lung cancer 
patients. The correlation factor has been shown to be very good, especially with Model 2 
(which compensates for phase shifts), being always superior to 0.95, and leading to an 
average prediction error of 0.8mm and error at a 95% confidence level of 2.1mm. The 
small prediction error and the high correlation between diaphragm position and tumor 15 
position with the linear models used in this work lead to the conclusion that diaphragm 
motion is a good surrogate for indirect tumor position estimation. It should be noted that 
if non-linear models were considered in addition to linear models, results should   
improve, or at least not get worse. Gated treatment or tumor tracking can clearly benefit 
from the good correlation here found. While tumor is not always visible in fluoroscopic 20 
images and it cannot be directly tracked, the diaphragm has a high contrast edge that can 
be automatically identified at the required rate for a successful online estimation and 
treatment. 
diaphragm 
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It has been observed that the correlation between diaphragm motion and tumor 
motion varies from patient to patient. Therefore a specific training set to build the model 
should be used for each individual. While performance of the models here developed 
show that in general there is a linear (and therefore predictable) relationship between 
diaphragm and tumor motion, this has not been the case for Patient3. Although adding 5 
new surrogates to the model seems to improve the results, error is still larger than desired. 
Therefore the appropriateness of a linear relationship between diaphragm and tumor 
motions should be assessed for every patient. Patients like Patient3 in this study, who 
present a difference in the shape of diaphragm motion trajectory and tumor motion 
trajectory that cannot be explained by a simple amplitude change and time delay, might 10 
benefit from the development of a non-linear model. 
We would like to acknowledge that one limitation of the presented study is that it 
only considers craniocaudal tumor motion. Lateral and AP motions usually have smaller 
amplitude than superior-inferior motion, and lead to large noise in the marked trajectory 
when fluoroscopic images are manually marked. Although it is expected that the 15 
correlation of diaphragm motion and lateral and AP tumor motion is also good, a similar 
study where the 2D or 3D tumor position is known should be performed in the future.  
In our prediction power study 200 images were used to build the prediction model. In 
contrast, other correlation studies normally use 4D-CT images, which consist on about 10 
breathing phases (van der Weide et al., 2008; Zhang et al., 2007). One of the problems of 20 
these 4D-CT studies is that the scans at the diaphragm axial position and the scans at each 
tumor position correspond to different breathing cycles, which might have different 
breathing amplitudes. Once scans are divided into phase bins, although corresponding to 
the same breathing phase, they might correspond to different amplitudes, and therefore 
diaphragm position in one of those bins might not correspond to the tumor position 25 
identified in the same bin. We believe that a study that uses real time position is more 
accurate than using 4D-CT data. 
This paper only intended to evaluate correlation of tumor and diaphragm. Variability 
of the model correlation and slope throughout different sequences has been analyzed in 
several patients. A future study will evaluate whether the model built for one treatment 30 
fraction can predict motion during a different fraction or inter-fraction variation of the 
correlation is too large to use the model from one fraction for prediction in another 
fraction. 
In summary, radiotherapy treatments based on surrogate imaging rely on the good 
correlation of the tumor motion with respect to the surrogate. We have seen in the present 35 
study that this correlation is good when using diaphragm as a surrogate, and that it can be 
improved by using more sophisticated correlation models. However, this correlation is 
patient specific, and it should be examined for each patient individually before it is used 
for deriving the tumor position.  
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